TrialBlood neoplasia2026

Health-related quality of life with linvoseltamab treatment for relapsed/refractory multiple myeloma in LINKER-MM1.

James E Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.